We discovered that RGE inhibits PD-1/PD-L1 interaction by in vitro protein binding ELISA and suppresses cell growth of CRC by increasing tumor-infiltrated CD8+ T cells immune function in co-culture cell model. The gene discussed is CD8A; the disease is colorectal carcinoma.